Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Takeda Pharmaceutical (TKPHF) over the last 7 years, with Q4 2025 value amounting to 0.47%.

  • Takeda Pharmaceutical's Return on Invested Capital rose 800.0% to 0.47% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.47%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.02% for FY2025, which is 300.0% down from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Return on Invested Capital stood at 0.47%, which was up 800.0% from 0.31% recorded in Q3 2025.
  • Takeda Pharmaceutical's Return on Invested Capital's 5-year high stood at 0.47% during Q4 2025, with a 5-year trough of 0.06% in Q2 2023.
  • Over the past 5 years, Takeda Pharmaceutical's median Return on Invested Capital value was 0.12% (recorded in 2022), while the average stood at 0.18%.
  • Per our database at Business Quant, Takeda Pharmaceutical's Return on Invested Capital soared by 2800bps in 2024 and then tumbled by -800bps in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Return on Invested Capital (Quarter) stood at 0.15% in 2021, then dropped by -27bps to 0.11% in 2022, then rose by 27bps to 0.14% in 2023, then soared by 180bps to 0.39% in 2024, then rose by 22bps to 0.47% in 2025.
  • Its Return on Invested Capital stands at 0.47% for Q4 2025, versus 0.31% for Q3 2025 and 0.25% for Q2 2025.